Timothy Rittman
Timothy Rittman
Clinical Lecturer, University of Cambridge
Verified email at medschl.cam.ac.uk - Homepage
TitleCited byYear
Transcriptional data: a new gateway to drug repositioning?
F Iorio, T Rittman, H Ge, M Menden, J Saez-Rodriguez
Drug discovery today 18 (7-8), 350-357, 2013
1472013
Adolescence is associated with genomically patterned consolidation of the hubs of the human brain connectome
KJ Whitaker, PE Vértes, R Romero-Garcia, F Váša, M Moutoussis, ...
Proceedings of the National Academy of Sciences 113 (32), 9105-9110, 2016
1432016
Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers
U Müller, JB Rowe, T Rittman, C Lewis, TW Robbins, BJ Sahakian
Neuropharmacology 64, 490-495, 2013
1152013
T1‐weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease
ST Schwarz, T Rittman, V Gontu, PS Morgan, N Bajaj, DP Auer
Movement Disorders 26 (9), 1633-1638, 2011
1092011
The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
T Rittman, BC Ghosh, P McColgan, DP Breen, J Evans, CH Williams-Gray, ...
J Neurol Neurosurg Psychiatry 84 (5), 544-551, 2013
772013
Validation of the new consensus criteria for the diagnosis of corticobasal degeneration
SK Alexander, T Rittman, JH Xuereb, TH Bak, JR Hodges, JB Rowe
J Neurol Neurosurg Psychiatry 85 (8), 925-929, 2014
752014
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease
Z Ye, E Altena, C Nombela, CR Housden, H Maxwell, T Rittman, ...
Brain 137 (4), 1145-1155, 2014
722014
Multiple modes of impulsivity in Parkinson's disease
C Nombela, T Rittman, TW Robbins, JB Rowe
PloS one 9 (1), e85747, 2014
682014
Improving response inhibition in Parkinson’s disease with atomoxetine
Z Ye, E Altena, C Nombela, CR Housden, H Maxwell, T Rittman, ...
Biological psychiatry 77 (8), 740-748, 2015
652015
The medial frontal-prefrontal network for altered awareness and control of action in corticobasal syndrome
N Wolpe, JW Moore, CL Rae, T Rittman, E Altena, P Haggard, JB Rowe
Brain 137 (1), 208-220, 2013
612013
Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy
TE Cope, T Rittman, RJ Borchert, PS Jones, D Vatansever, K Allinson, ...
Brain 141 (2), 550-567, 2018
592018
Gene transcription profiles associated with inter-modular hubs and connection distance in human functional magnetic resonance imaging networks
PE Vértes, T Rittman, KJ Whitaker, R Romero-Garcia, F Váša, ...
Philosophical Transactions of the Royal Society B: Biological Sciences 371 …, 2016
562016
Atomoxetine restores the response inhibition network in Parkinson’s disease
CL Rae, C Nombela, PV Rodríguez, Z Ye, LE Hughes, PS Jones, T Ham, ...
Brain 139 (8), 2235-2248, 2016
422016
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in P arkinson's disease with clinical and neuroimaging measures
Z Ye, CL Rae, C Nombela, T Ham, T Rittman, PS Jones, PV Rodríguez, ...
Human brain mapping 37 (3), 1026-1037, 2016
402016
Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson’s disease
J Zhang, T Rittman, C Nombela, A Fois, I Coyle-Gilchrist, RA Barker, ...
Brain 139 (1), 161-173, 2015
402015
Improving response inhibition systems in frontotemporal dementia with citalopram
LE Hughes, T Rittman, R Regenthal, TW Robbins, JB Rowe
Brain 138 (7), 1961-1975, 2015
342015
Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy
T Rittman, M Rubinov, PE Vértes, AX Patel, CE Ginestet, BCP Ghosh, ...
Neurobiology of aging 48, 153-160, 2016
312016
Atomoxetine enhances connectivity of prefrontal networks in Parkinson’s disease
RJ Borchert, T Rittman, L Passamonti, Z Ye, S Sami, SP Jones, ...
Neuropsychopharmacology 41 (8), 2171, 2016
272016
Neurophysiological signatures of Alzheimer’s disease and frontotemporal lobar degeneration: pathology versus phenotype
S Sami, N Williams, LE Hughes, TE Cope, T Rittman, ITS Coyle-Gilchrist, ...
Brain 141 (8), 2500-2510, 2018
112018
Managing cognition in progressive supranuclear palsy
T Rittman, ITS Coyle-Gilchrist, JB Rowe
Neurodegenerative disease management 6 (6), 499-508, 2016
102016
The system can't perform the operation now. Try again later.
Articles 1–20